JCI - Citations to Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis.

Citations to this article

Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis.

M Ferretti, … , C C Nast, F Cominelli

M Ferretti, … , C C Nast, F Cominelli

Published July 1, 1994
Citation Information: J Clin Invest. 1994;94(1):449-453. https://doi.org/10.1172/JCI117345.

View: Text | PDF

Research Article

Total citations by year

Year:	2024	2021	2020	2019	2018	2017	2015	2014	2013	2012	2011	2010	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	Total
Citations:	3	2	1	3	1	4	3	2	8	4	7	4	1	3	3	4	5	7	5	6	7	5	17	6	8	6	1	126

Citation information

Citations to this article (128)

Title and authors	Publication	Year
IL-1RA autoantibodies: insights into mechanisms and associated diseases. Bouayad A	American journal of translational research	2024
The aetiology of pouchitis in patients with inflammatory bowel disease. Alenzi M, Schildkraut T, Hartley I, Badiani S, Ding NS, Rao V, Segal JP	Therapeutic advances in gastroenterology	2024
IL-1 receptor antagonist: etiological and drug delivery systems overview. Ubhe A	Inflammation research : official journal of the European Histamine Research Society ... [et al.]	2024
15-Deoxy-△12,14-Prostaglandin J2 Promotes Resolution of Experimentally Induced Colitis W Kim, JH Jang, X Zhong, H Seo, YJ Surh	Frontiers in immunology	2021
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches G Privitera, D Pugliese, LR Lopetuso, F Scaldaferri, M Neri, L Guidi, A Gasbarrini, A Armuzzi	Therapeutic advances in gastroenterology	2021
Fecal transplantation for ulcerative colitis: current evidence and future applications LR Lopetuso, G Ianiro, JR Allegretti, S Bibbò, A Gasbarrini, F Scaldaferri, G Cammarota	Expert Opinion on Biological Therapy	2020
Neutralization of IL-1α ameliorates Crohn’s disease-like ileitis by functional alterations of the gut microbiome P Menghini, D Corridoni, LF Buttó, A Osme, S Shivaswamy, M Lam, G Bamias, TT Pizarro, A Rodriguez-Palacios, CA Dinarello, F Cominelli	Proceedings of the National Academy of Sciences	2019
Interleukin 1 is a key driver of inflammatory bowel disease-demonstration in a murine IL-1Ra knockout model RH Dosh, N Jordan-Mahy, C Sammon, CL Maitre	Oncotarget	2019
Ulcerative Colitis and Familial Mediterranean Fever: Can Anakinra Treat Both? L Kaly, M Rozenbaum, D Rimar, G Slobodin, N Boulman, A Awisat, S Ginsberg, N Jiries, I Rosner	ACG Case Reports Journal	2019
Updated review on immune factors in pathogenesis of Crohn’s disease N Li, RH Shi	World journal of gastroenterology : WJG	2018
Regulation of Inflammatory Signaling in Health and Disease D Xu	Regulation of Inflammatory Signaling in Health and Disease	2017
Interleukin 1 gene polymorphism and susceptibility to disease K Khazim, EE Azulay, B Kristal, I Cohen	Immunological Reviews	2017
Biomarkers for nonclinical infusion reactions in marketed biotherapeutics and considerations for study design KM Mease, AL Kimzey, JA Lansita	Current Opinion in Toxicology	2017
Alpha-Tocopheryl Succinate-Conjugated G5 PAMAM Dendrimer Enables Effective Inhibition of Ulcerative Colitis Y Wang, W Shen, X Shi, F Fu, Y Fan, W Shen, Y Cao, Q Zhang, R Qi	Advanced Healthcare Materials	2017
IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer E Voronov, RN Apte	Cancer Microenvironment	2015
Interleukin-1α, an Epithelial Danger Signal, Is a Potent Activator of Fibroblasts and Reactivator of Intestinal Inflammation M Scarpa, S Kessler, T Sadler, G West, C Homer, C McDonald, C la Motte, C Fiocchi, E Stylianou	The American Journal of Pathology	2015
Wheat germ agglutinin anchored chitosan microspheres of reduced brominated derivative of noscapine ameliorated acute inflammation in experimental colitis K Kaur, RK Sodhi, A Katyal, R Aneja, UK Jain, OP Katare, J Madan	Colloids and Surfaces B: Biointerfaces	2015
The Dual Role of Nod-Like Receptors in Mucosal Innate Immunity and Chronic Intestinal Inflammation D Corridoni, KO Arseneau, MG Cifone, F Cominelli	Frontiers in immunology	2014
Neurotensin--regulated miR-133 is involved in proinflammatory signalling in human colonic epithelial cells and in experimental colitis IK Law, K Bakirtzi, C Polytarchou, A Oikonomopoulos, D Hommes, D Iliopoulos, C Pothoulakis	Gut	2014
Negative regulation of human mononuclear phagocyte function M Hedl, C Abraham	Mucosal Immunology	2013
Relevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and Transcriptomic [corrected] characterization and correlation to IBD Ø Brenna, MW Furnes, I Drozdov, AB Granlund, A Flatberg, AK Sandvik, RT Zwiggelaar, R Mårvik, IS Nordrum, M Kidd, BI Gustafsson	PloS one	2013
Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers: Curcumin as TNF blocker BB Aggarwal, SC Gupta, B Sung	British Journal of Pharmacology	2013
Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease LR Lopetuso, S Chowdhry, TT Pizarro	Frontiers in immunology	2013
Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis R Marcon, AF Bento, RC Dutra, MA Bicca, DF Leite, JB Calixto	Journal of immunology (Baltimore, Md. : 1950)	2013
Relevance of TNBS-Colitis in Rats: A Methodological Study with Endoscopic, Histologic and Transcriptomic Characterization and Correlation to IBD Ø Brenna, MW Furnes, I Drozdov, AB Granlund, A Flatberg, AK Sandvik, RT Zwiggelaar, R Mårvik, IS Nordrum, M Kidd, BI Gustafsson, B Foligne	PloS one	2013
Mechanism of Interleukin-1β Induced-Increase in Mouse Intestinal Permeability In Vivo R Al-Sadi, S Guo, K Dokladny, MA Smith, D Ye, A Kaza, DM Watterson, TY Ma	Journal of Interferon & Cytokine Research	2012
Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis LR Lopetuso, F Scaldaferri, TT Pizarro	Fibrogenesis & Tissue Repair	2012
New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation G Bamias, D Corridoni, TT Pizarro, F Cominelli	Cytokine	2012
Mucosal imbalance of interleukin-1β and interleukin-1 receptor antagonist in canine inflammatory bowel disease S Maeda, K Ohno, K Nakamura, K Uchida, K Nakashima, K Fukushima, A Tsukamoto, Y Goto-Koshino, Y Fujino, H Tsujimoto	The Veterinary Journal	2012
Inhibitor of PI3Kγ ameliorates TNBS-induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3+ regulatory T cells RC Dutra, M Cola, DF Leite, AF Bento, RF Claudino, AF Nascimento, PC Leal, JB Calixto	British Journal of Pharmacology	2011
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases CA Dinarello	Blood	2011
The TLR7 ligand Imiquimod induces type I IFN and antimicrobial peptides to ameliorate DSS-induced acute colitis SK Sainathan, KS Bishnupuri, K Aden, Q Luo, CW Houchen, S Anant, BK Dieckgraefe	Inflammatory Bowel Diseases	2011
Cytokines L Cassetta, G Poli, M Alfano	Cytokines	2011
Preventive and Therapeutic Euphol Treatment Attenuates Experimental Colitis in Mice RC Dutra, RF Claudino, AF Bento, R Marcon, EC Schmidt, ZL Bouzon, LF Pianowski, JB Calixto	PloS one	2011
Mitochondria at the interface between danger signaling and metabolism: Role of unfolded protein responses in chronic inflammation E Rath, D Haller	Inflammatory Bowel Diseases	2011
Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation L Pastorelli, CD Salvo, MA Cominelli, M Vecchi, TT Pizarro	Therapeutic advances in gastroenterology	2011
Inflammatory Bowel Disease A Kaser, S Zeissig, RS Blumberg	Annual Review of Immunology	2010
Anti-inflammatory Agents: Present and Future CA Dinarello	Cell	2010
Interleukin and Interleukin Receptor Diversity: Role of Alternative Splicing A Sahoo, SH Im	International Reviews of Immunology	2010
Why not treat human cancer with interleukin-1 blockade? CA Dinarello	Cancer metastasis reviews	2010
Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease O Ludwiczek, E Vannier, A Moschen, A Salazar-Montes, I Borggraefe, C Gabay, B Enrich, A Kaser, B Siegmund, C Dinarello, H Tilg	Scandinavian Journal of Gastroenterology	2008
Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis SK Sainathan, EM Hanna, Q Gong, KS Bishnupuri, Q Luo, M Colonna, FV White, E Croze, C Houchen, S Anant, BK Dieckgraefe	Inflammatory Bowel Diseases	2007
Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1β W Hu, S Mahavadi, F Li, KS Murthy	American journal of physiology. Cell physiology	2007
Vagus nerve integrity and experimental colitis JE Ghia, P Blennerhassett, SM Collins	AJP Gastrointestinal and Liver Physiology	2007
The Vagus Nerve: A Tonic Inhibitory Influence Associated With Inflammatory Bowel Disease in a Murine Model JE Ghia, P Blennerhassett, H Kumar–Ondiveeran, EF Verdu, SM Collins	Gastroenterology	2006
Serum interleukin-1 receptor antagonist is an early indicator of colitis onset in Galphai2-deficient mice OH Hultgren, M Berglund, M Bjursten, EH Hörnquist	World journal of gastroenterology : WJG	2006
Serum interleukin-1 receptor antagonist is an early indicator of colitis onset in Gαi2-deficient mice OH Hultgren	World journal of gastroenterology : WJG	2006
Intestinal mucosal responses to microbial infection L Eckmann, MF Kagnoff	Springer Seminars in Immunopathology	2005
Activation of A2A Adenosine Receptor Attenuates Intestinal Inflammation in Animal Models of Inflammatory Bowel Disease M Odashima, G Bamias, J Rivera-Nieves, J Linden, CC Nast, CA Moskaluk, M Marini, K Sugawara, K Kozaiwa, M Otaka, S Watanabe, F Cominelli	Gastroenterology	2005
International Review of Neurobiology ZT Bloomgarden	International review of neurobiology	2005
Mucosal Immunology WR Brown	Mucosal Immunology	2005
Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease O Ludwiczek, E Vannier, I Borggraefe, A Kaser, B Siegmund, CA Dinarello, H Tilg	Clinical & Experimental Immunology	2004
Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis W Cao	AJP Gastrointestinal and Liver Physiology	2004
Interleukin 1 -Induced Production of H2O2 Contributes to Reduced Sigmoid Colonic Circular Smooth Muscle Contractility in Ulcerative Colitis W Cao	The Journal of pharmacology and experimental therapeutics	2004
Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis MJ Carter, S Jones, NJ Camp, A Cox, J Mee, B Warren, GW Duff, AJ Lobo, FS di Giovine	Genes and Immunity	2004
Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression VS Carl, JK Gautam, LD Comeau, MF Smith	Journal of leukocyte biology	2004
Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis J Ji, J Sun, L Soong	Infection and immunity	2003
In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii S Ricci, G Macchia, P Ruggiero, T Maggi, P Bossù, L Xu, D Medaglini, A Tagliabue, L Hammarström, G Pozzi, D Boraschi	BMC Biotechnology	2003
Association between the interleukin-1 receptor antagonist polymorphism and ulcerative colitis with younger age at diagnosis H Nohara, N Inoue, T Hibi, K Okita, Y Hinoda	Immunology Letters	2003
Interleukin-1β and Interleukin-1RA Serum and Stool Levels in the Course of Salmonellosis MS Stoycheva, MA Murdjeva	Biotechnology & Biotechnological Equipment	2003
Curcumin attenuates DNB-induced murine colitis B Salh, K Assi, V Templeman, K Parhar, D Owen, A Gómez-Muñoz, K Jacobson	AJP Gastrointestinal and Liver Physiology	2003
Inflammatory Bowel Disease: From Bench to Bedside SR Targan, F Shanahan, LC Karp		2003
Microbial Pathogenesis and the Intestinal Epithelial Cell GA Hecht		2003
Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases DS Hallegua, MH Weisman	Annals of the rheumatic diseases	2002
Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage PV Sivakumar, GM Westrich, S Kanaly, K Garka, TL Born, JM Derry, JL Viney	Gut	2002
Amelioration of dextran sulfate sodium–induced colitis by anti-macrophage migration inhibitory factor antibody in mice T Ohkawara, J Nishihira, H Takeda, S Hige, M Kato, T Sugiyama, T Iwanaga, H Nakamura, Y Mizue, M Asaka	Gastroenterology	2002
Leptin: A pivotal mediator of intestinal inflammation in mice B Siegmund, HA Lehr, G Fantuzzi	Gastroenterology	2002
The balance between IL-1 and IL-1Ra in disease William P Arend	Cytokine & Growth Factor Reviews	2002
Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians MJ Carter, FS di Giovine, S Jones, J Mee, NJ Camp, AJ Lobo, GW Duff	Gut	2001
Inflammatory Bowel Disease KD Taylor, H Yang, JI Rotter	Molecular Genetics and Metabolism	2001
The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis MJ Carter, FS di Giovine, A Cox, P Goodfellow, S Jones, AJ Shorthouse, GW Duff, AJ Lobo	Gastroenterology	2001
Role of endogenous interleukin-1 receptor antagonist in regulating fever induced by localised inflammation in the rat T Cartmell, GN Luheshi, SJ Hopkins, NJ Rothwell, S Poole	The Journal of Physiology	2001
Endogenous IL-1 and Type II IL-1 Receptor Expression Modulate Anoikis in Intestinal Epithelial Cells CC Waterhouse, RR Joseph, AW Stadnyk	Experimental Cell Research	2001
Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin-1 receptor antagonist W P Arend	Seminars in Arthritis and Rheumatism	2001
Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6 R Daig, G Rogler, E Aschenbrenner, D Vogl, W Falk, V Gross, J Schölmerich, T Andus	Gut	2000
Biological role of interleukin 1 receptor antagonist isoforms WP Arend, CJ Guthridge	Annals of the rheumatic diseases	2000
Increased expression of mRNA encoding interleukin-1? and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration C Eriksson, R Tehranian, K Iverfeldt, B Winblad, M Schultzberg	Journal of Neuroscience Research	2000
New immunophormacologic approaches to asthma: Role of cytokine antagonism LJ Rosenwasser	Journal of Allergy and Clinical Immunology	2000
Interleukin-1 family: from genes to human disease B Laurincova	Biomedical Papers	2000
XI. Novel mouse models to study pathogenic mechanisms of Crohn's disease TT Pizarro, KO Arseneau, F Cominelli	AJP Gastrointestinal and Liver Physiology	2000
Novel Cytokine Inhibitors GA Higgs, B Henderson		2000
The Role of Therapeutic Apheresis in the Treatment of Cancer: A Review MR Lentz	Therapeutic Apheresis and Dialysis	1999
Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis NA Tountas, V Casini–Raggi, H Yang, FS di Giovine, M Vecchi, L Kam, L Melani, TT Pizarro, JI Rotter, F Cominelli	Gastroenterology	1999
Combination therapy of pentoxifylline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis Murthy, Cooper, Yoshitake, Meyer, Meyer, Murthy	Alimentary Pharmacology & Therapeutics	1999
Rapid Expression of IL-1β by Intestinal Epithelial Cellsin Vitro CC Waterhouse, AW Stadnyk	Cellular Immunology	1999
Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action AV Turnbull, CL Rivier	Physiological reviews	1999
Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells AJ Puren, G Fantuzzi, Y Gu, MS Su, CA Dinarello	Journal of Clinical Investigation	1998
Differential expression of interleukin 1 receptor antagonist isoforms in human intestinal epithelial cells U Böcker, A Damião, L Holt, DS Han, C Jobin, A Panja, L Mayer, RB Sartor	Gastroenterology	1998
Inflammatory bowel disease: Etiology and pathogenesis C Fiocchi	Gastroenterology	1998
Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor Antagonist CA Dinarello	International Reviews of Immunology	1998
INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology WP Arend, M Malyak, CJ Guthridge, C Gabay	Annual Review of Immunology	1998
Biologic activities of IL-1 and its role in human disease DM Essayan, CC Fox, F Levi-Schaffer, R Alam, LJ Rosenwasser	Journal of Allergy and Clinical Immunology	1998
The Th1 and Th2 cytokines IFN-γ and IL-4 antagonize the inhibition of monocyte IL-1 receptor antagonist by glucocorticoids: involvement of IL-1 D Kovalovsky, MP Pereda, J Sauer, CP Castro, VE Nahmod, GK Stalla, F Holsboer, E Arzt	European Journal of Immunology	1998
Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) 1beta and IL-1 receptor antagonist gene polymorphisms Hacker, Bidlingmaier, Gomolka, Keller, Eigler, Hartmann, Chr. Folwaczny, Fricke, Albert, Loeschke, Endres	European Journal of Clinical Investigation	1998
Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD) S Dionne, ID D'Agata, J Hiscott, T Vanounou, EG Seidman	Clinical & Experimental Immunology	1998
Involvement of TNF α, IL-1β and IL-1 Receptor Antagonist in LPS-induced Rabbit Uveitis JS Mo, A Matsukawa, S Ohkawara, M Yoshinaga	Experimental Eye Research	1998
Relationship between Interleukin-1 and Interleukin-1 Receptor Antagonist during the Development of Fever in the Rata T Cartmell, S Poole, NJ Rothwell, GN Luheshi	Annals of the New York Academy of Sciences	1998
Enzymatic amplification and expression of bovine interleukin-1 receptor antagonist cDNA R Kirisawa, T Fukuda, H Yamanaka, K Hagiwara, M Goto, Y Obata, T Yoshino, H Iwai	Veterinary Immunology and Immunopathology	1998
Kainic acid induced expression of interleukin-1 receptor antagonist mRNA in the rat brain C Eriksson, B Winblad, M Schultzberg	Molecular Brain Research	1998
Subtherapeutic corticosteroids potentiate the ability of interleukin 10 to prevent chronic inflammation in rats H H Herfarth, U Böcker, R Janardhanam, R B Sartor	Gastroenterology	1998
Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies B Xia	World journal of gastroenterology : WJG	1998
DOES INCREASED URINARY INTERLEUKIN-1 RECEPTOR ANTAGONIST/INTERLEUKIN-1?? RATIO INDICATE GOOD PROGNOSIS IN RENAL TRANSPLANT RECIPIENTS?: AM Teppo, E Honkanen, J Ahonen, C Gronhagen-Riska	Transplantation	1998
Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies. Xia B, Crusius J, Meuwissen S, Pe?a A	World Journal of Gastroenterology	1998
Cytokines in inflammatory bowel disease PL Beck, JL Wallace	Mediators of Inflammation	1997
Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis UT Hacker, M Gomolka, E Keller, A Eigler, C Folwaczny, H Fricke, E Albert, K Loeschke, S Endres	Gut	1997
Endogenous Interleukin-1 Receptor Antagonist is Neuroprotective SA Loddick, ML Wong, PB Bongiorno, PW Gold, J Licinio, NJ Rothwell	Biochemical and Biophysical Research Communications	1997
Involvement of tumor necrosis factor-α, interleukin-I β, interleukin-8, and interleukin-I receptor antagonist in acute lung injury caused by local Shwartzman reaction S Imamura, A Matsukawa, S Ohkawara, M Kagayama, M Yoshinaga	Pathology International	1997
Molecular cloning and functional expression of equine interleukin-1 receptor antagonist H Kato, T Ohashi, H Matsushiro, T Watari, R Goitsuka, H Tsujimoto, A Hasegawa	Veterinary Immunology and Immunopathology	1997
Regulatory effects of endogenous interleukin-1 receptor antagonist protein in immunoglobulin G immune complex-induced lung injury TP Shanley, JL Peters, ML Jones, SW Chensue, SL Kunkel, PA Ward	Journal of Clinical Investigation	1996
Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice E Hirsch, VM Irikura, SM Paul, D Hirsh	Proceedings of the National Academy of Sciences	1996
Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits T Fukumoto, A Matsukawa, S Ohkawara, K Takagi, M Yoshinaga	Inflammation Research	1996
Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis BE Drevlow, R Lovis, MA Haag, JM Sinacore, C Jacobs, C Blosche, A Landay, LW Moreland, RM Pope	Arthritis & Rheumatism	1996
Inducible osteonecrosis in a rabbit serum sickness model: Deposition of immune complexes in bone marrow K Nakata	Bone	1996
MOLECULAR BIOLOGY OF CYTOKINES IN ALLERGIC DISEASES AND ASTHMA S Fishman, K Hobbs, L Borish	Immunology and Allergy Clinics of North America	1996
IL-1 stimulates intestinal myofibroblast COX gene expression and augments activation of Cl- secretion in T84 cells TA Hinterleitner, JI Saada, HM Berschneider, DW Powell, JD Valentich	American journal of physiology. Cell physiology	1996
Pathology of Septic Shock ET Rietschel, H Wagner		1996
The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor D Burger, R Chicheportiche, JG Giri, JM Dayer	Journal of Clinical Investigation	1995
Anti-inflammatory effects of CGP 47969A, a novel inhibitor of proinflammatory cytokine synthesis, in rabbit immune colitis V Casini-Raggi, L Monsacchi, K Vosbeck, CC Nast, TT Pizarro, F Cominelli	Gastroenterology	1995
Epidermal cytokines in allergic contact dermatitis S Kondo, DN Sauder	Journal of the American Academy of Dermatology	1995
A question of balance: ups and downs of mucosal inflammation MF Kagnoff	Journal of Clinical Investigation	1994
Biologic therapy for inflammatory bowel disease BE Sands	Inflammatory Bowel Diseases
Experimental models of inflammatory bowel disease CO Elson, RB Sartor, GS Tennyson, RH Riddell	Gastroenterology	1995
Biologic Therapy for Inflammatory Bowel Disease: BE Sands	Inflammatory Bowel Diseases
IL-1 and EGF regulate expression of genes important in inflammation and cancer A Kasza	Cytokine	2013
Emery and Rimoin's Principles and Practice of Medical Genetics DC Wallace, MT Lott, V Procaccio	Emery and Rimoin's Principles and Practice of Medical Genetics	2013
Zinc-controlled Th1/Th2 switch significantly determines development of diseases JE Sprietsma	Medical Hypotheses	1997
Mapping Receptor Binding Sites in Interleukin (IL)-1 Receptor Antagonist and IL-1β by Site-directed Mutagenesis RJ Evans, J Bray, JD Childs, GP Vigers, BJ Brandhuber, RC Thompson, SP Eisenberg, JJ Skalicky	The Journal of biological chemistry	1995
CURRENT CONCEPTS OF THE ETIOLOGY AND PATHOGENESIS OF ULCERATIVE COLITIS AND CROHN’S DISEASE RB Sartor	Gastroenterology Clinics of North America	1995

Advertisement